Substantia Nigra Pars Reticulata Projections to the Pedunculopontine Nucleus Modulate Dyskinesia
Open Access
- 17 July 2023
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 38 (10) , 1850-1860
Abstract
Background: Long‐term use of levodopa for Parkinson's disease (PD) treatment is often hindered by development of motor complications, including levodopa‐induced dyskinesia (LID). The substantia nigra pars reticulata (SNr) and globus pallidus internal segment (GPi) are the output nuclei of the basal ganglia. Dysregulation of SNr and GPi activity contributes to PD pathophysiology and LID.Objective: The objective of this study was to determine whether direct modulation of SNr GABAergic neurons and SNr projections to the pedunculopontine nucleus (PPN) regulates PD symptoms and LID in a mouse model.Methods: We expressed Cre‐recombinase activated channelrhodopsin‐2 (ChR2) or halorhodopsin adeno‐associated virus‐2 (AAV2) vectors selectively in SNr GABAergic neurons of Vgat‐IRES‐Cre mice in a 6‐hydroxydopamine model of PD to investigate whether direct optogenetic modulation of SNr neurons or their projections to the PPN regulates PD symptoms and LID expression. The forepaw stepping task, mouse LID rating scale, and open‐field locomotion were used to assess akinesia and LID to test the effect of SNr modulation.Results: Akinesia was improved by suppressing SNr neuron activity with halorhodopsin. LID was significantly reduced by increasing SNr neuronal activity with ChR2, which did not interfere with the antiakinetic effect of levodopa. Optical stimulation of ChR2 in SNr projections to the PPN recapitulated direct SNr stimulation.Conclusions: Modulation of SNr GABAergic neurons alters akinesia and LID expression in a manner consistent with the rate model of basal ganglia circuitry. Moreover, the projections from SNr to PPN likely mediate the antidyskinetic effect of increasing SNr neuronal activity, identifying a potential novel role for the PPN in LID. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.Keywords
Funding Information
- National Institute of Neurological Disorders and Stroke (R21NS108068)
- Parkinson's Foundation
This publication has 75 references indexed in Scilit:
- Effect of globus pallidus internus stimulation on neuronal activity in the pedunculopontine tegmental nucleus in the primate model of Parkinson's diseaseExperimental Neurology, 2012
- Leptin Action on GABAergic Neurons Prevents Obesity and Reduces Inhibitory Tone to POMC NeuronsNeuron, 2011
- Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson's diseaseNeurobiology of Disease, 2011
- Enhanced striatal cholinergic neuronal activity mediatesl-DOPA–induced dyskinesia in parkinsonian miceProceedings of the National Academy of Sciences, 2010
- Goal-directed and habitual control in the basal ganglia: implications for Parkinson's diseaseNature Reviews Neuroscience, 2010
- Chronic 3,4-dihydroxyphenylalanine treatment induces dyskinesia in aphakia mice, a novel genetic model of Parkinson’s diseaseNeurobiology of Disease, 2007
- In 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-Treated Primates, the Selective 5-Hydroxytryptamine 1a Agonist (R)-(+)-8-OHDPAT Inhibits Levodopa-Induced Dyskinesia but Only with\ Increased Motor DisabilityThe Journal of Pharmacology and Experimental Therapeutics, 2006
- Consequences of partial and severe dopaminergic lesion on basal ganglia oscillatory activity and akinesiaEuropean Journal of Neuroscience, 2005
- Loss of bidirectional striatal synaptic plasticity in L-DOPA–induced dyskinesiaNature Neuroscience, 2003
- The functional anatomy of basal ganglia disordersTrends in Neurosciences, 1989